A Trial of Sertraline in Young Children With Autism Spectrum Disorder
Status:
Completed
Trial end date:
2018-07-01
Target enrollment:
Participant gender:
Summary
This study is a control trial of sertraline (Zoloft) in children aged 2 to 5 years old
inclusive with Autism Spectrum Disorder. The trial is six months long, and each participant
will receive a series of tests at both the beginning and end of the study. The researchers
hope to show improvements in language and social deficits.
Phase:
Phase 2
Details
Lead Sponsor:
Randi J. Hagerman, MD University of California, Davis
Collaborator:
Health Resources and Services Administration (HRSA)